Haemonetics Corp. (HAE): Net earnings per share (EPS TTM)

Haemonetics Corporation (HAE) - corporate logo

Stable demand for plasma collection consumables provides Haemonetics Corporation (HAE) with a steady cash flow. Net income per share over the last 12 months (TTM) confirms this trend, with the metric recorded at 2.26. This is supported by a wide range of blood transfusion systems in clinics and the optimization of electronic component supply chains to ensure uninterrupted production.

Haemonetics Corporation (HAE) - Earnings per share for the trailing year from 07/04/2022 to 11/14/2026

Analytical breakdowns and data insights for company Haemonetics Corp (HAE)

- stock price and consensus target price:
Stock Price Haemonetics Corporation|HAE - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Haemonetics Corporation|HAE - Real Price to Acquire Entire Company
- business book valuation details:
Accounting Value per Share Haemonetics|HAE - Accounting Value of Company|Market Value to Book Value Ratio haemonetics.com|HAE - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Haemonetics Corporation|HAE - Long-Term Liabilities to Capital|Short-Term Debt to Capital Haemonetics Corp.|HAE - Company Aggregate Debt|Debts to Book Capitalization Haemonetics Corporation|HAE - Long-Term Debt Volume|Company Short-Term Debts Haemonetics|Quick Ratio haemonetics.com
- earnings and valuation multiples indicators:
HAE - Net Profit|Expected Profit Haemonetics Corporation|HAE - Price to Earnings Ratio|Projected Price to Earnings Haemonetics|HAE - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Haemonetics Corporation|HAE - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Haemonetics|HAE - Net earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months haemonetics.com|HAE - Earnings growth in current year|Earnings growth forecast for next year Haemonetics Corporation
- issuer revenue and sales details:
HAE - Company Gross Revenue|Company Projected Revenue Haemonetics Corporation|HAE - Price-to-Sales Ratio|Price-to-Projected Revenue Ratio Haemonetics Corporation
Fundamental valuation:Haemonetics Corporation (HAE)
Manufactured products of Haemonetics Corp

For an investor in Haemonetics Corporation (HAE), this metric serves as a gauge of profit generation efficiency per share, which is critical for valuing a business in the low-cyclical medical equipment sector. Analyzing the 12-month net income per share trend reveals the result of dividing total annual profit by the number of shares, confirming the high resilience of the company's capital to macroeconomic shocks.

Competitors of Haemonetics Corporation

DexCom, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters penumbrainc.com PEN|NOVT: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Inspire Medical|Net earnings per share for the last 12 months PRCT|CNMD: Earnings per share for the trailing year|Earnings per share for the last twelve months Pulse Biosciences, Inc. (PLSE)|Net earnings per share for the last 12 months inmodemd.com INMD|Net earnings per share (EPS TTM) PMI (Picard Medical)|Surmodics Inc (SRDX) - Net earnings per one share for the last twelve months|Eversense - Net earnings per share (EPS TTM)|NPCE (NeuroPace Medical) - Earnings per share for the last 12 months|TCMD: Net earnings per share (EPS TTM)|SNWV - Net earnings per share for the last four quarters|OM (Outset Medical) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Electromed Inc (ELMD)|Net earnings per share (EPS TTM) LNSR|Net earnings per share (EPS TTM) AVITA Medical Inc (RCEL)|Earnings per share for the last twelve months Profound Medical PROF|Baird Medical Investment Holdings - Earnings per share for the last twelve months|EDAP: Net earnings per share for the last 12 months|Earnings per share for the trailing year APYX (Apyx Medical)|ICCM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Pulmonx (LUNG)|Earnings per share for the last twelve months TELA Bio Inc.|CTSO - Net earnings per share for the trailing year|Net earnings per share for the last 12 months SRTS (Sensus Healthcare)|Net earnings per share (EPS TTM) Zynex Medical (ZYXI)|Net earnings per share (EPS TTM) ECOR (electroCore)|Net earnings per share for the last four quarters Vicarious Surgical Inc (RBOT)|IINN - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ICU|iridex.com (IRIX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Intelligent Bio Solutions Inc.|XAIR (Beyond Air Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Profusa, Inc PFSA|Earnings per share for the last twelve months STRATA Skin Sciences (SSKN)|glucotrack.com - Earnings per share for the last 12 months|NanoVibronix - Net earnings per share for the last 12 months|Earnings per share for the last four quarters VERO (Venus Concept Inc)|CHF Solutions - Net earnings per share (EPS TTM)|Earnings per share for the trailing year AEMD (Aethlon Medical Corp)|ASXC: Net earnings per share (EPS TTM)|avinger.com (AVGR) - Net earnings per share (EPS TTM)|BSGM (BioSig) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cutera Inc. CUTR|Earnings per share for the last twelve months Know Labs Corp (KNW)|Net earnings per share for the last 12 months Inari Medical Corp NARI|Earnings per share for the last twelve months Nevro Corp. NVRO|ReShape Lifesciences, Inc. (RSLS) - Net earnings per one share for the last twelve months|SILK - Earnings per share for the last twelve months